Verweij, Paul E.Ananda-Rajah, MichelleAndes, DavidArendrup, Maiken C.Bruggemann, Roger J.Chowdhary, AnuradhaCornely, Oliver A.Denning, David W.Groll, Andreas H.Izumikawa, KoichiKullberg, Bart JanLagrou, KatrienMaertens, JohanMeis, Jacques F.Newton, PippaPage, IainSeyedmousavi, SeyedmojtabaSheppard, Donald C.Viscoli, ClaudioDonnelly, J. PeterWarris, Aafje2016-09-162016-09-162015Verweij, P E, Ananda-Rajah, M, Andes, D, Arendrup, M C, Bruggemann, R J, Chowdhary, A, Cornely, O A, Denning, D W, Groll, A H, Izumikawa, K, Kullberg, B J, Lagrou, K, Maertens, J, Meis, J F, Newton, P, Page, I, Seyedmousavi, S, Sheppard, D C, Viscoli, C, Donnelly, J P & Warris, A 2015, 'International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus', Drug Resistance Updates, vol. 21-22, pp. 30-40. https://doi.org/10.1016/j.drup.2015.08.0011368-7646http://hdl.handle.net/2164/7487Acknowledgements We thank Gilead Sciences Europe Ltd., UK for financially supporting logistical aspects of this study. The logistics of the meeting were handled by Congress Care, Den Bosch, The Netherlands. The sponsor was not involved in the selection of the participants or procedures, or in the discussion, data collection, analysis or writing of the manuscript. The medical writer was financially supported by the Dutch Society for Medical Mycology and the Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.111120484engAzole resistanceInvasive aspergillosisChronic aspergillosisAspergillus fumigatusVoriconazoleChronic pulmonary aspergillosisCentral-nervous-systemLiposomal amphotericin-BPharmacodynamic Target DeterminationBronchoalveolar lavage fluidAntifungal TherapyTR34/L98H MutationsCYP51A geneWild-typeRS Pharmacy and materia medicaRSJournal item10.1016/j.drup.2015.08.00121